Awards and credibility SureScreen Diagnostics has earned prestigious King's Awards for Enterprise in Innovation and International Trade, which signals strong market credibility and potential for multi-region expansion conversations with healthcare procurement leads and government buyers.

Public sector traction Past and ongoing Department of Health and Social Care engagement, including a significant £500 million testing contract, indicates a track record with government health programs that can be leveraged to pursue additional public sector opportunities and NHS-adjacent procurement channels.

Rapid diagnostics focus With a long history since 1996 in proactive diagnostic solutions and recent emphasis on Covid-19 antigen tests, there is a strong case for upselling enhanced rapid test kits, companion digital tools, and tailored support services to clinical laboratories and corporate wellness programs.

Strategic partnerships Collaborations like the Guy’s and St Thomas’ NHS Foundation Trust app initiative demonstrate appetite for integrated testing workflows; this opens doors for SDRs to position SureScreen as a provider of interoperable testing solutions and data-friendly platforms in hospital networks.

Growing market fit Operating with modest team size (51-200 employees) and revenue in the low-to-mid millions, SureScreen presents a scalable target for mid-market healthcare vendors and regional distributors seeking to expand into UK/Europe through channel partnerships and managed services.